Efficacy and Safety of Early Versus Delayed Administration of Everolimus in de Novo Renal Transplant Patients
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate if the delayed administration of everolimus could
reduce the everolimus associated "anti-proliferative complications" (e.g. wound healing
disorder) while maintaining efficacy, when compared to the immediate administration of
everolimus in de novo renal transplant patients.